Cutting Edge: Novel vaccination modality provides significant protection against mucosal infection by highly pathogenic simian immunodeficiency virus

Journal of Immunology

Volumn 190, Issue 6, 2013, Pages 2495-2499

  Strbo, Natasa ^a   Vaccari, Monica ^b   Pahwa, Savita ^a   Kolber, Michael A ^a   Doster, Melvin N ^b   Fisher, Eva ^a   Gonzalez, Louis ^a   Stablein, Donald ^c   Franchini, Genoveffa ^b   Podack, Eckhard R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CHAPERONE; FAS ANTIGEN; GLYCOPROTEIN 96; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRIPARTITE MOTIF PROTEIN 5; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CELLULAR SECRETION; CONTROLLED STUDY; EFFECTOR CELL; ENDOPLASMIC RETICULUM; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; MALE; MUCOSA INFLAMMATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN VIRUS; VIRUS STRAIN; VIRUS TITRATION; VIRUS VIRULENCE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; COHORT STUDIES; FEMALE; HEK293 CELLS; HUMANS; INJECTIONS, INTRAPERITONEAL; INTESTINAL MUCOSA; MACACA MULATTA; MALE; MEMBRANE GLYCOPROTEINS; MUCOUS MEMBRANE; RECTAL DISEASES; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84874823295     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202655     Document Type: Article

References (22)

1. Vabulas, R. M., S. Braedel, N. Hilf, H. Singh-Jasuja, S. Herter, P. Ahmad-Nejad, C. J. Kirschning, C. Da Costa, H. G. Rammensee, H. Wagner, and H. Schild. 2002. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J. Biol. Chem. 277: 20847-20853
2. Binder, R. J., D. K. Han, and P. K. Srivastava. 2000. CD91: a receptor for heat shock protein gp96. Nat. Immunol. 1: 151-155
3. Arnold, D., S. Faath, H. Rammensee, and H. Schild. 1995. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J. Exp. Med. 182: 885-889
4. Singh-Jasuja, H., H. U. Scherer, N. Hilf, D. Arnold-Schild, H. G. Rammensee, R. E. Toes, and H. Schild. 2000. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur. J. Immunol. 30: 2211-2215
5. Yamazaki, K., T. Nguyen, and E. R. Podack. 1999. Cutting edge: tumor secreted heat shock-fusion protein elicits CD8 cells for rejection. J. Immunol. 163: 5178- 5182
6. Oizumi, S., N. Strbo, S. Pahwa, V. Deyev, and E. R. Podack. 2007. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes. J. Immunol. 179: 2310-2317
7. Strbo, N., S. Pahwa, M. A. Kolber, L. Gonzalez, E. Fisher, and E. R. Podack. 2010. Cell-secreted Gp96-Ig-peptide complexes induce lamina propria and intraepithelial CD8+ cytotoxic T lymphocytes in the intestinal mucosa. Mucosal Immunol. 3: 182- 192
8. Strbo, N., M. Vaccari, S. Pahwa, M. A. Kolber, E. Fisher, L. Gonzalez, M. N. Doster, A. Hryniewicz, B. K. Felber, G. N. Pavlakis, et al. 2011. Gp96 SIV Ig immunization induces potent polyepitope specific, multifunctional memory responses in rectal and vaginal mucosa. Vaccine 29: 2619-2625
9. Liu, J., K. L. O'Brien, D. M. Lynch, N. L. Simmons, A. La Porte, A. M. Riggs, P. Abbink, R. T. Coffey, L. E. Grandpre, M. S. Seaman, et al. 2009. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457: 87-91
10. Letvin, N. L., S. S. Rao, D. C. Montefiori, M. S. Seaman, Y. Sun, S. Y. Lim, W. W. Yeh, M. Asmal, R. S. Gelman, L. Shen, et al. 2011. Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys. Sci. Transl. Med. 3: 81ra36
11. Hansen, S. G., J. C. Ford, M. S. Lewis, A. B. Ventura, C. M. Hughes, L. Coyne- Johnson, N. Whizin, K. Oswald, R. Shoemaker, T. Swanson, et al. 2011. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473: 523-527
12. Rerks-Ngarm, S., P. Pitisuttithum, S. Nitayaphan, J. Kaewkungwal, J. Chiu, R. Paris, N. Premsri, C. Namwat, M. de Souza, E. Adams, et al MOPH-TAVEG Investigators. 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361: 2209-2220
13. Barouch, D. H., K. L. O'Brien, N. L. Simmons, S. L. King, P. Abbink, L. F. Maxfield, Y. H. Sun, A. La Porte, A. M. Riggs, D. M. Lynch, et al. 2010. Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. Nat. Med. 16: 319-323
14. Haynes, B. F., P. B. Gilbert, M. J. McElrath, S. Zolla-Pazner, G. D. Tomaras, S. M. Alam, D. T. Evans, D. C. Montefiori, C. Karnasuta, R. Sutthent, et al. 2012. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 366: 1275-1286
15. McMichael, A. J., and B. F. Haynes. 2012. Lessons learned from HIV-1 vaccine trials: new priorities and directions. Nat. Immunol. 13: 423-427
16. Hansen, S. G., C. Vieville, N. Whizin, L. Coyne-Johnson, D. C. Siess, D. D. Drummond, A. W. Legasse, M. K. Axthelm, K. Oswald, C. M. Trubey, et al. 2009. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat. Med. 15: 293-299
17. Vaccari, M., A. Boasso, Z. M. Ma, V. Cecchinato, D. Venzon, M. N. Doster, W. P. Tsai, G. M. Shearer, D. Fuchs, B. K. Felber, et al. 2008. CD4+ T-cell loss and delayed expression of modulators of immune responses at mucosal sites of vaccinated macaques following SIV(mac251) infection. Mucosal Immunol. 1: 497-507
18. Brocca-Cofano, E., K. McKinnon, T. Demberg, D. Venzon, R. Hidajat, P. Xiao, M. Daltabuit-Test, L. J. Patterson, and M. Robert-Guroff. 2011. Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia. Vaccine 29: 3310-3319
19. Florese, R. H., T. Demberg, P. Xiao, L. Kuller, K. Larsen, L. E. Summers, D. Venzon, A. Cafaro, B. Ensoli, and M. Robert-Guroff. 2009. Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines. J. Immunol. 182: 3718-3727
20. Wrammert, J., K. Smith, J. Miller, W. A. Langley, K. Kokko, C. Larsen, N. Y. Zheng, I. Mays, L. Garman, C. Helms, et al. 2008. Rapid cloning of highaffinity human monoclonal antibodies against influenza virus. Nature 453: 667- 671
21. Fenizia, C., B. F. Keele, D. Nichols, S. Cornara, N. Binello, M. Vaccari, P. Pegu, M. Robert-Guroff, Z. M. Ma, C. J. Miller, et al. 2011. TRIM5a does not affect simian immunodeficiency virus SIV(mac251) replication in vaccinated or unvaccinated Indian rhesus macaques following intrarectal challenge exposure. J. Virol. 85: 12399-12409
22. Barouch, D. H., J. Liu, H. Li, L. F. Maxfield, P. Abbink, D. M. Lynch, M. J. Iampietro, A. SanMiguel, M. S. Seaman, G. Ferrari, et al. 2012. Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys. Nature 482: 89-93